首页> 外国专利> Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines

Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines

机译:合成肽及其使用方法用于检测人类免疫缺陷病毒(HIV)gp120包膜蛋白的抗体,诊断AIDS和AIDS前的状况以及用作疫苗

摘要

This invention relates to a method using synthetic peptides as the solid phase immunoadsorbent for the detection and elicitation of antibodies to Human Immunodeficiency Virus (HIV) gp120, and, in particular, antibodies having HIV neutralizing capabilities. The amino acid sequences of the peptides correspond to segments of the external envelope protein gp120 of HIV. These peptides have been found to be highly immunogenic, and are reactive with antibodies in sera of patients with AIDS, ARC or HIV infected individuals. They can also be used to elicit the production of neutralizing antibodies to HIV. More specifically, the present invention is directed to the use of a synthetic peptide selected from the groups consisting of peptides containing thirty- three amino acids in a prescribed sequence derived from the HIV-gp120 external protein, analogues, mixtures and poly-L- lysine polymers thereof, for the detection and elicitation of antibodies to HIV-gp120. It is particularly useful for the detection and elicitation of antibodies having HIV neutralizing capabilities. The detection method includes an enzyme linked immunoassay and other forms of immunoassay procedures. The present invention also relates to a method for generating high titer neutralizing antibodies to HIV gp120 protein in healthy mammals, including humans, by the use of the synthetic peptides, their analogues or mixtures in either a conjugated or a polymeric form as a key component in a synthetic vaccine for the prevention of AIDS.
机译:本发明涉及一种使用合成肽作为固相免疫吸附剂来检测和引发针对人类免疫缺陷病毒(HIV)gp120的抗体,特别是具有HIV中和能力的抗体的方法。肽的氨基酸序列对应于HIV的外部包膜蛋白gp120的区段。已经发现这些肽是高度免疫原性的,并且在患有AIDS,ARC或HIV感染的个体的患者血清中与抗体反应。它们还可以用于引发针对HIV的中和抗体的产生。更具体地,本发明涉及选自肽的合成肽的用途,所述肽包含从HIV-gp120外部蛋白衍生的以规定的顺序包含33个氨基酸的肽,类似物,混合物和聚-L-赖氨酸。用于检测和诱导针对HIV-gp120的抗体的聚合物。它对于检测和引发具有HIV中和能力的抗体特别有用。检测方法包括酶联免疫测定和其他形式的免疫测定程序。本发明还涉及一种通过使用合成肽,其类似物或共轭或聚合形式的混合物作为关键组分在人体内的健康哺乳动物(包括人)中产生针对HIV gp120蛋白的高滴度中和抗体的方法。预防艾滋病的合成疫苗。

著录项

  • 公开/公告号US5763160A

    专利类型

  • 公开/公告日1998-06-09

    原文格式PDF

  • 申请/专利权人 UNITED BIOMEDICAL INC.;

    申请/专利号US19950488252

  • 发明设计人 CHANG YI WANG;

    申请日1995-06-07

  • 分类号C12Q1/70;G01N33/569;C07K14/16;A61K39/21;

  • 国家 US

  • 入库时间 2022-08-22 02:39:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号